Al Franken actually said...

"I believe that we can make the FDA processes more efficient, more predictable, and better support and reward biomedical innovation."

"I think we can all agree that patient safety is a priority of Congress and a priority of the FDA."

"I plan to work on the three policy issues that I touched on in my questions, communication between the FDA and the industry, unnecessarily restrictive conflict of interest rules, and the profit cap on..."

"This is part of the 7(a) process."